Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Dysplasia 12Keratosis, Actinic 11Melanoma 7Carcinoma, Basal Cell 7Glioma 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Glioblastoma 4Precancerous Conditions 3Hutchinson's Melanotic Freckle 3Vulvar Neoplasms 2Neoplasm Metastasis 2Hemangioma, Capillary 2Ependymoma 2Brain Neoplasms 2Astrocytoma 2Vaginal Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pigmentation Disorders 1Patient Satisfaction 1Papillomavirus Infections 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms 1

Interventions

toripalimab 1pembrolizumab 1bicalutamide 1Lidocaine 1Imiquimod 1Fluorescein 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Paget Disease, Extramammary × Imiquimod × Clear all
NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡